Acasti Pharma to Present at The American Academy of Anti-Aging Medicine (A4M) and to The American Academy of Private Physicians Dec 7, 2011
Acasti Pharma Announces the Initiation of a Second Phase II Clinical Study and Consolidation of Its IP Position Dec 5, 2011
Acasti Pharma Inc. Receives Health Canada Clearance for an Open-Label Phase II Hypertriglyceridemia Trial Oct 17, 2011
Acasti Pharma Announces the Initiation of Phase II Clinical Study of CaPre(R) for the Treatment of Hypertriglyceridemia Oct 4, 2011